2007
DOI: 10.1016/j.jaci.2006.12.399
|View full text |Cite
|
Sign up to set email alerts
|

Sophorolipids Decrease IgE Production in U266 Cells by Downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 0 publications
0
20
0
Order By: Relevance
“…In addition, earlier research by our group established many SL small molecule derivatives that are anti-inflammatory. [30][31][32][33][34] Thus, it is worthwhile to explore in future studies whether polyLSLs or their degradation products still possess this property that is highly desirable for biomaterial applications such as implants. Besides, sophorose derivatives were reported to bind lectins with high to mild affinity.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, earlier research by our group established many SL small molecule derivatives that are anti-inflammatory. [30][31][32][33][34] Thus, it is worthwhile to explore in future studies whether polyLSLs or their degradation products still possess this property that is highly desirable for biomaterial applications such as implants. Besides, sophorose derivatives were reported to bind lectins with high to mild affinity.…”
Section: Resultsmentioning
confidence: 99%
“…[26][27][28][29] Furthermore, our laboratory working with collaborators reported SLs have excellent potential as therapeutic agents. [30][31][32][33][34] When pure oleic acid is used as the lipid feedstock to produce SLs by fermentation, the main product is an unusual diacetylated lactonic sophorolipid, LSL[6'Ac, 6"Ac], shown in Scheme-1. Earlier work exploring the conversion of SLs to glycopolymers involved the use of a multi-step synthetic approach giving SL pendant groups appended to an acrylate main chain 35 and lipase-catalyzed ROP of lactonic SLs that gave low molecular weight products.…”
Section: Introductionmentioning
confidence: 99%
“…For example, they were used as treatment in vivo to decrease sepsis‐related mortality in experimental sepsis . Moreover, recent studies demonstrated that SLs possess antibacterial , antiviral , and anti‐inflammatory properties. In order to enhance or modulate these properties, modification of SL structure has been attempted during their microbial production by varying the lipophilic substrates in fermentation media and by genetic engineering to alter the biosynthetic pathway .…”
Section: Introductionmentioning
confidence: 99%
“…The mechanisms involved in these studies included a decrease in nitric oxide production and proinflammatory cytokines [2,5,7]. Recent studies in our laboratory also demonstrated the utility of sophorolipids in atopic disease [11]; sophorolipids were able to decrease IgE production in a dose-dependent manner and used mechanisms involving the reduction of IgErelated genes, including BSAP (Pax5) and IL-6 among others [12]. In all cases, there were no deleterious effects to the host or somatic cell lines in vitro and in vivo at therapeutic doses.…”
Section: Discussionmentioning
confidence: 98%